Ipratropium bromide intranasal - Chiesi

Drug Profile

Ipratropium bromide intranasal - Chiesi

Alternative Names: RinoAtem; RinoAtem Aqua

Latest Information Update: 08 Jun 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chiesi
  • Class Antiasthmatics; Antibronchitics; Atropine derivatives; Bronchodilators; Small molecules
  • Mechanism of Action Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Asthma; Chronic obstructive pulmonary disease; Rhinitis

Most Recent Events

  • 08 Jun 2010 No development reported - Phase-III for Rhinitis in Italy (Intranasal)
  • 08 Jun 2010 No development reported - Preregistration for Asthma in Italy (Intranasal)
  • 08 Jun 2010 No development reported - Preregistration for Chronic obstructive pulmonary disease in Italy (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top